Alder Biopharmaceutica Profile

18.85
USD 0.4  2.08%
90%
15%

Sale by Srb Associates Ix Lp of 16218 shares of Alder Biopharmaceutica

Alder Biopharmaceuticals insider trading alert for sale of common stock by Srb Associates Ix Lp, the corporate stakeholder, on July 15, 2018. This event was filed by Alder Biopharmaceuticals with SEC on 2015-09-02. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

Alder Biopharmaceutica Summary

Alder Biopharmaceuticals (ALDR) is traded on BATS Exchange in USA. It is located in WASHINGTON U.S.A and employs 193 people. Alder Biopharmaceutica is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Mid-Cap' category with current market capitalization of 1.25 B. Alder Biopharmaceuticals conducts business under Healthcare sector and is part of Biotechnology industry. This company has 67.85 M outstanding shares of which 12.13 M shares are presently shorted by private and institutional investors with about 9.32 trading days to cover. Alder BioPharmace currently holds about 330.96 M in cash with (239.31 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.88.
Check Alder Biopharmaceutica Probability Of Bankruptcy

Ownership Allocation (%)

Target Price Odds Analysis

Odds Below 18.85HorizonTargetOdds Above 18.85
92.32%30 days 18.85 7.61%
Based on normal probability distribution, the odds of Alder Biopharmaceutica to move above current price in 30 days from now is about 7.61% (This Alder Biopharmaceuticals probability density function shows the probability of Alder Biopharmaceutica Stock to fall within a particular range of prices over 30 days) .

Top Holders

Selected Alder Biopharmaceuticals Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Alder Biopharmaceutica Against Markets

Risk Adjusted
Performance Score (0 to 100)
10 
Chance of
Financial Distress (0 to 100%)
18 
Equity ratings for Alder Biopharmaceuticals are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Alder BioPharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. Alder BioPharmaceuticals, Inc. was incorporated in 2002 and is headquartered in Bothell, Washington. Alder Biopharmaceutica operates under Biotechnology classification in USA and traded on NASDAQ General Markets. It employs 193 people. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
Alder Biopharmaceutica SEC Filings
Alder Biopharmaceutica SEC Filings
Security & Exchange Commission EDGAR ReportsView All
NameAlder Biopharmaceuticals
President CEORobert AzelbyView All
Thematic Classification
Currently Active Investing Idea
  Biotech
View All
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Specialization
Healthcare, Biotechnology
InstrumentUSA Stock View All
RegionNorth America
LocationWASHINGTON U.S.A
Business Address11804 North Creek Parkway South
ExchangeBATS Exchange
CIK Number0001423824
CUSIP014339105
SectorHealthcare
IndustryBiotechnology
BenchmarkDOW
Websitewww.alderbio.com
Phone425 205 2900
CurrencyUSD - US Dollar

Alder Biopharmaceutica Corporate Directors

Deepa Pakianathan Independent Director, MBA
Bruce Montgomery Independent Director
Deepika Pakianathan Independent Director, MBA
Check also Trending Equities. Please also try Content Syndication module to quickly integrate customizable finance content to your own investment portal.